INTRODUCTION

Intracellular Ca 2 +
signals play important roles in many biological processes, including gene expression, secretion, Ca 2 + homoeostasis, cell growth, proliferation, differentiation and apoptosis [1] . The Ca 2 + signal is derived either from the external medium or the internal Ca 2 + stores [2] . In the case of the former, the SOCE (store-operated calcium entry) is one of the very important resources for receptor-evoked Ca 2 + influx in many cell types. For the latter, the ER (endoplasmic reticulum) and its muscle counterpart, the SR (sarcoplasmic reticulum), are the main Ca 2 + storage compartments. The release of Ca 2 + from the internal Ca 2 + stores is controlled by several Ca 2 + channels located on the endomembrane system, of which the IP 3 R [Ins(1,4,5)P 3 receptor] and the RyR (ryanodine receptor) are the two most important channels. Under physiological conditions, several pathways can lead to the depletion of the internal Ca 2 + stores [3] . A variety of extracellular ligands activate PM (plasma membrane)-located receptors that stimulate PLCs (phospholipase Cs) to generate Ins(1,4,5)P 3 . Ins(1,4,5)P 3 then binds to the IP 3 R in the membrane of the ER, releasing Ca 2 + from the intracellular Ca 2 + stores. The subsequent depletion of Ca 2 + from the ER triggers a Ca 2 + influx through store-operated Ca 2 + channels located in the PM to elevate the intracellular free Ca 2 + concentration ([Ca 2 + ] i ) [4] . The molecular mechanism underlying SOCE has remained unclear for more than two decades until the discovery of two key elements: STIM1 (stromal interaction molecule 1) [5] [6] [7] , that senses Ca 2 + levels in the ER membrane, and Orai1 [8] [9] [10] [11] , that forms the CRAC (Ca 2 + release-activated Ca 2 + ) channel pore located in the PM. Upon store depletion, STIM1 oligomerizes and translocates to the cell periphery near the plasma membrane, where it forms puncta and activates the CRAC channel [12] [13] [14] [15] .
In the basal state, STIM1 is in a closed conformation due to contributions by the ER luminal [16, 17] and cytosolic [18] [19] [20] portions. The mechanism of auto-inhibition in the STIM1-NT (STIM1 N-terminus) is indisputable because the atomic structure of STIM1-NT has been solved [16, 17] . Nevertheless, the auto-inhibitory mechanism and intramolecular interactions of the STIM1-CT (STIM1 C-terminus) are controversial. Kawasaki et al. [21] proposed that the CAD (CRAC-activating domain) was masked by an adjacent 31-amino-acid peptide (445-475), referred to in the present study as the second inhibitory domain, preventing efficient CRAC channel activation in cells with replete Ca 2 + stores. Korzeniowski et al. [20] suggested that a segment of acidic amino acid residues in the CC1 (coiled-coil 1) domain interacted with a segment of basic amino acid residues in the Cterminus of CC2 by electrostatic interaction, resulting in a closed conformation of STIM1-CT in the quiescent state. Muik et al. [19] showed that several hydrophobic bonds in the OASF (Orai1-activating small fragment) maintained the CAD in an impeded state when the Ca 2 + stores were full. Recent crystallographic analyses provided valuable insight into the structure and intramolecular control of SOAR (STIM1-Oraiactivating region) activation. Yang et al. [18] , who crystallized the entire CC domain of CeSTIM1 (Caenorhabditis elegans STIM1), suggested that part of the CC1 domain (residues Abbreviations used: BAPTA, 1,2-bis-(o-aminophenoxy)ethane-N,N,N ,N -tetra-acetic acid; CAD, CRAC-activating domain; CC, coiled-coil; CeSTIM1, Caenorhabditis elegans stromal interaction molecule 1; CRAC, Ca 2 + -release-activated Ca 2 + ; ER, endoplasmic reticulum; HEK, human embryonic kidney; hSTIM1, human stromal interaction molecule 1; IP 3 R, Ins(1,4,5)P 3 receptor; mGFP, monomeric GFP; PM, plasma membrane; PMCA, PM Ca 2 + -ATPase; SERCA, sarcoplasmic/endoplasmic reticulum Ca 2 + -ATPase; SOCE, store-operated calcium entry; STIM1, stromal interaction molecule 1; STIM1-CT, STIM1 C-terminus; STIM1-NT, STIM1 N-terminus; TG, thapsigargin; WT, wild-type. 1 These authors contributed equally to this work. 2 Correspondence may be addressed to either of these authors (email xutao@ibp.ac.cn or pyxu@ibp.ac.cn).
310-337) of hSTIM1 (human STIM1), which corresponds to a segment (residues 257-279) of CeSTIM1, may act as another inhibitory unit to keep hSTIM1 in an inactive resting state by interacting with CAD via hydrogen and hydrophobic bonds. We refer to this region as the first inhibitory unit in the present study. Combined with our previous studies that indicated that CeSTIM1 localizes in the periphery of quiescent cells when expressed in mammalian cells [22] , we propose that CeSTIM1 and hSTIM1 must have different auto-inhibition mechanisms because they exhibited different behaviours in ER-replete cells and vastly different amino acid sequences in their inhibitory domains. The amino acid sequence alignment showed two additional segments in the hSTIM1 CC1 domain, a long segment (residues 272-300) and a short segment (residues 310-317), which is absent in the CeSTIM1 α A helix domain (Supplementary Figure S1 at http://www.biochemj.org/bj/454/bj4540401add.htm).
Because it was in the putative inhibitory domain, our attention was drawn to the additional short segment (residues 310-317) as opposed to the CeSTIM1 α A helix domain. In the present study, a mutant, STIM1-DI, was constructed by deleting residues 310-317, and a series of single-site mutants were engineered by substituting the polar and charged amino acids with an alanine residue in the segment of hSTIM1. These mutants were used to investigate mutation-induced behavioural changes in comparison with WT (wild-type) STIM1. We found that STIM1-DI and a single-site mutant STIM1-Y316A could constitutively activate the CRAC channel in its resting state. On the basis of these results, we guessed that the additional short segment (residues 310-317) in hSTIM1 determined the different localizations of human and CeSTIM1 in resting cells. Further in vitro experiments showed that an introduction of the Y316A mutation in the first inhibitory domain caused the higher-order oligomerization of a purified protein fragment containing both the auto-inhibitory domain and CAD.
On the basis of the above results, we proposed that, in the quiescent state, the STIM1 Tyr 316 residue in the first inhibitory domain might play a central role in keeping STIM1-CT in the locked/inactive state. Furthermore, we proposed two possible auto-inhibitory mechanisms: first, Tyr 316 of STIM1 may play a crucial role in forming an intramolecular interaction with the CAD by hydrogen bonds and hydrophobic bonds. Mutating STIM1 to replace Tyr 316 with an alanine residue may release the CAD from the locked state. Secondly, the inactive/resting STIM1 is maintained by the intermolecular repulsive forces, which prevent the formation of STIM1 oligomers. Mutation of Y316A might eliminate the intermolecular repulsive forces among STIM1 molecules, leading to ready formation of clusters and translocation of STIM1 to the PM to activate Oria1. • C in a 5 % CO 2 humidified incubator.
Plasmids and transfection
To obtain a pmGFP-N1 plasmid, the Ala 206 residue of EGFP was mutated to a lysine residue on the basis of a pEGFP-N1 plasmid according to the method outlined by Zacharias et al. [23] . To produce pmOrange2-N1 and 3×FLAG-N1 plasmids, segments of mOrange2 or 3×FLAG amplified from PCR were used to substitute EGFP in the pEGFP-N1 vector. C-terminally mGFP (monomeric GFP)-or 3×FLAG-tagged STIM1 constructs were cloned via HindIII and XmaI restriction sites on the pmGFP-N1 or p3×FLAG-N1 vectors respectively. The C-terminally mOrange2-tagged Orai1 construct was cloned via XhoI and EcoRI restriction sites on the pmOrange2-N1 vector. The STIM1-DImGFP mutant was constructed by deleting the short inhibitory domain (residues 310-317) and the series of single-site mutants of STIM1 were produced by oligonucleotide-directed mutagenesis using a standard protocol. To construct prokaryotic expression vectors, pET.HGB.3C was double-digested by BamHI and XholI, and then, the STIM1-(246-455) or STIM1-(246-455)-Y316A segment amplified by PCR was inserted respectively. All constructs were confirmed by sequencing. For transfection, the indicated amount of DNA (1.6 μg of STIM1 was used for single plasmid transfection; 0.4 μg of Orai1 and 1.2 μg of STIM1 were used for regular double plasmids co-transfection; 0.1 μg of Orai1 and 0.3 μg of STIM1 were used for a low amount of plasmids cotransfection) was transiently transfected into HEK-293 cells in a 12-well plate at 80-90 % confluency using Lipofectamine TM 2000 (Invitrogen) according to the manufacturer's instructions. For the constitutively active constructs, 1.75 mM EGTA and 10 μM La 3 + were added to the medium after transfection to avoid the toxicity of spontaneous Ca 2 + influx.
Confocal imaging
Transiently transfected HEK-293 cells were seeded on to sterile poly-D-lysine-coated coverslips and cultured for an additional 24 h before imaging. Transfected cells were imaged under a confocal laser-scanning microscope FV1000 (Olympus Optical) in 2 mM Ca 2 + Ringer's solution containing 155 mM NaCl, 4.5 mM KCl, 2 mM CaCl 2 , 1 mM MgCl 2 , 10 mM D-glucose and 5 mM Hepes (pH 7.4). For the store depletion experiments, images in the resting state were acquired before addition of 2 μM TG (thapsigargin; Sigma-Aldrich) to the bath, and images in the ER depletion state were collected 8 min later.
Immunoprecipitation and Western blotting
HEK-293 cells seeded on 10-cm-diameter dishes were transiently transfected with STIM1-3×FLAG or STIM1-Y316A-3×FLAG. At 36 h after transfection, cells were harvested in PBS and lysed in 1 ml of RIPA lysis buffer containing 50 mM Tris/HCl, pH 7.4, 150 mM NaCl, 1 % Triton X-100, 1 % sodium deoxycholate, 0.1 % SDS and protease inhibitors at 4
• C. All subsequent steps were performed at 4
• C. The cell lysates were immunoprecipitated with monoclonal anti-FLAG M2 antibody produced in mouse (Sigma-Aldrich) according to the manufacturer's instructions. Immunoprecipitated proteins were separated by electrophoresis on SDS/PAGE (10 % gels) and probed with a 1:5000 dilution of an anti-FLAG antibody (Sigma) or a 1:1000 dilution of an anti-phosphotyrosine antibody (4G10; Millipore). Signals were detected by ECL (Pierce).
Single cell [Ca 2 + ] i measurement
Transiently transfected HEK-293 cells were loaded with 5 μM fura-2/AM (fura 2 acetoxymethyl ester; Invitrogen) in medium for 25 min at 37
• C and washed three times with PBS before imaging. The experiments were performed with a dual-wavelength c The Authors Journal compilation c 2013 Biochemical Society excitation fluorometric imaging system (Till Photonics) in conjunction with an inverted microscope (IX71; Olympus) in a standard 2 mM Ca 2 + Ringer's solution. A single mGFP-and mOrange2-positive cell was excited with wavelengths of 340 and 380 nm produced by a monochromator (polychrome IV; Till Photonics), and signals were collected with a photodiode controlled by a TILL fluorometic system and the X-chart extension of the Pulse software (HEKA). All experiments were performed in a perfusion chamber with a low volume and a high solution exchange rate at room temperature (25
• C). The standard 2 mM Ca 2 + Ringer's solution was used as described above. For the 0 mM Ca 2 + solution, 1 mM EGTA and 2 mM MgCl 2 were used to substitute for 2 mM Ca 2 + based on a standard 2 mM Ca 2 + Ringer's solution. Ca 2 + determination was performed as described previously [24] .
Electrophysiology
Patch-clamp experiments were performed in a tight-seal, wholecell configuration at room temperature. High-resolution current recordings were acquired with the EPC10 (HEKA) controlled by Pulse software. Immediately after establishing the wholecell configuration, CRAC channel currents were monitored continuously by voltage ramps spanning from − 100 mV to 100 mV over 50 ms delivered at 0.5 Hz. Current signals were sampled at 20 kHz and filtered at 2.9 kHz. Voltages were corrected for liquid-junction potential. Pipettes and cell capacitances were compensated before each voltage ramp. Ramp currents after highseal formation and before break-in with current amplitudes at + 50 mV equal to the sustained outward currents after break-in were classified as leak currents. Pipettes with 2-5 M resistances were filled with an internal solution containing 140 mM caesium glutamate, 8 mM MgCl 2 , 10 mM BAPTA [1,2-bis-(oaminophenoxy)ethane-N,N,N ,N -tetra-acetic acid] and 10 mM Hepes (adjusted to pH 7.2 with CsOH). The standard external solution contained the following: 145 mM NaCl, 4.5 mM KCl, 1 mM MgCl 2 , 6 mM CaCl 2 , 10 mM D-glucose, 10 mM tetraethylammonium and 5 mM Hepes (adjusted to pH 7.4 with NaOH). The current amplitude at − 100 mV of the individual ramp was used for statistical analysis.
Protein expression and purification
The STIM1-(246-455) and STIM1-(246-455)-Y316A proteins were expressed in the Escherichia coli strain BL21(DE3)pLysS and purified using a Ni-NTA (Ni 2 + -nitrilotriacetate) His-Bind resin (Qiagen), followed by a gel-filtration step using a Superdex 200 column (GE Healthcare). For additional analysis, purified proteins were concentrated by ultrafiltration and diluted in PBS.
Analysis of oligomerization
Size-exclusion chromatography was performed using a Superdex 200 column and anÄKTA purifier system (GE Healthcare) to check the aggregation properties of STIM1-(246-455) and STIM1-(246-455)-Y316A. Before chromatography, proteins were concentrated to 3-4 mg/ml. The flow rate was set to 0.5 ml/min. Protein absorption was monitored at 280 nm. All measurements were performed at 16
• C.
Data analysis
Data analysis was conducted using IGOR Pro 5.01 (Wavemetrics). Averaged results were presented as the means + − S.E.M. for the indicated number of experiments (n). Statistical significance was evaluated using a Student's t test. Asterisks denote statistical significance as compared with control, with ***P < 0.001.
RESULTS
The STIM1-Y316A mutant spontaneously bound to the PM in the ER-replete state when expressed in HEK-293 cells alone
Residues in the additional short segment (residues 310-317) as opposed to the CeSTIM1 α A helix domain (Supplementary Figure S1) were individually mutated to an alanine residue to investigate whether the mutation could change the behaviour of hSTIM1 before or after ER depletion. We used WT STIM1 as a control and found that the WT STIM1 exhibited a diffuse distribution in the ER membrane in resting HEK-293 cells ( Figure 1A , upper panel). After ER depletion with 2 μM TG, WT STIM1 aggregated into puncta and migrated to the cell periphery ( Figure 1A , lower panel). In contrast, STIM1-Y316A was preoligomerized in puncta at the cell periphery prior to Ca 2+ -store depletion ( Figure 1B , upper panel), whereas other mutants in residues 310-317 did not differ from WT STIM1 when expressed in HEK-293 cells alone (results not shown). We noticed that residue 316 of hSTIM1 was a tyrosine residue that was easily phosphorylated by tyrosine kinase. Furthermore, Lopez et al. [25] proposed that STIM1 tyrosine phosphorylation is required for the STIM1-Orai1 association in human platelets. To study whether the spontaneous PM-binding behaviour of STIM1-Y316A in the absence of ER depletion resulted from the dephosphorylation of this site, the Tyr 316 residue was mutated to an aspartate residue, which could mimic the effects of constitutive phosphorylation [26, 27] . As shown in Figure 1 (C), STIM1-Y316D exhibited a behaviour similar to that of STIM1-Y316A when expressed in HEK-293 cells, suggesting that Tyr 316 might not be involved in phosphorylation. We next mutated the Tyr 316 residue to a phenylalanine residue, which has an aromatic ring similar to that in the tyrosine residue, but lacks the hydroxide radical so would not be phosphorylated. As shown in Figure 1(D) , the behaviour of STIM1-Y316F was similar to that of WT STIM1 not only before but also after ER depletion. It was interesting that, when the ER was depleted with 2 μM TG, the sizes and the intensity of the puncta further increased (circles and rectangles as examples) in the cells expressing STIM1-Y316A or STIM1-Y316D ( Figures 1B and 1C, lower panels) . Because previous reports showed that glutamate and aspartate do not necessarily mimic phosphorylation states [28, 29] , an immunoprecipitation analysis was performed to confirm whether the Tyr 316 site is involved in phosphorylation. HEK-293 cells expressing 3×FLAG-tagged WT STIM1 or STIM1-Y316A with or without ER depletion were lysed and immunoprecipitated with an anti-FLAG antibody and subsequently detected by an anti-FLAG ( Figure 1E , left-hand side) or an anti-phosphotyrosine ( Figure 1E , right-hand side) antibody. By using the left-hand side of Figure 1 (E) as a control to quantify the expression level of STIM1 WT and mutants, we found that the tyrosine phosphorylation of WT STIM1 existed in the resting or Ca 2 + -store depletion state ( Figure 1E , right-hand side). However, the tyrosine phosphorylation levels did not differ between WT STIM1 and STIM1-Y316A either before or after ER depletion ( Figure 1E) .
The results of the present study disagree with a previous report by Lopez et al. [25] , which showed that the tyrosine phosphorylation level increased after TG stimulation in human platelets. We attribute this discrepancy to the differences between HEK-293 cells and human platelets. On the basis of these findings, we proposed that the aromatic amino acid was indispensable in keeping STIM1 in a diffuse distribution when the ER is replete. In addition, we hypothesized that the constitutive binding of STIM1-Y316A to the PM without ER depletion did not involve phosphorylation or dephosphorylation.
STIM1-Y316A and STIM1-DI could constitutively co-localize in the periphery of cells with Orai1 in the ER-filled state
As our previous study indicated [22] , CeSTIM1 expressed in HEK-293 cells could constitutively form puncta at the cell periphery, but failed to induce aggregation of CeOrai1 (C. elegans Orai1); therefore, no CRAC channel current was detected in quiescent cells that co-expressed the two components. To test whether aggregated STIM1-Y316A in resting HEK-293 cells can induce Orai1 clustering, the two plasmids were co-transfected into HEK-293 cells. Simultaneously, WT STIM1 and Orai1 were cotransfected into cells as a control. As shown in Figure 2 (A), WT STIM1 was localized diffusely throughout the ER (Figure 2A , upper panels) in resting HEK-293 cells, and recruited Orai1 into puncta at the cell surface upon the depletion of Ca 2 + stores with 2 μM TG (Figure 2A, lower panels) . However, STIM1-Y316A co-localized with Orai1 before ER depletion ( Figure 2B , upper panels). Furthermore, STIM1-Y316D or STIM1-Y316F was co-transfected with Orai1 into HEK-293 cells. As shown in Figure 2 (C) (upper panels), STIM1-Y316D, which acted as a phospho-mimic, had the same behaviour as STIM1-Y316A when co-expressed with Orai1. Figure 2(D) showed that STIM1-Y316F, which could not be phosphorylated at residue 316 because it lacked a hydroxide radical, exhibited a similar behaviour as WT STIM1. Interestingly, when a hydrophilic amino acid (glutamate, serine or threonine) was used to replace Tyr 316 , all mutants showed the same behaviour as STIM1-Y316A when expressed alone or together with Orai1 in HEK-293 cells (results not shown). For those mutants with constitutive puncta, we also depleted ER Ca 2 + stores with TG. The stimulation changed the shapes of preformed puncta as shown in Figures 2(B) , 2(C) and 2(E) (lower panels, rectangles as examples). The pre-formed puncta were not caused by the artificial overexpression, as we could still see many puncta of STIM1-Y316A or STIM1-Y316D co-localized with Orai1 at the periphery in resting cells, when the expression level of these proteins were extremely low (Supplementary Figure S2 at http://www.biochemj.org/bj/454/bj4540401add.htm). However, the size and the intensity of the puncta decreased to a certain degree. Interestingly, TG stimulation further increased the size and the intensity of the puncta of STIM1-Y316A/STIM1-Y316D and Orai1 (circles and rectangles as examples).
On the basis of the above results, we proposed that the additional short segment (residues 310-317) might indeed have an inhibitory function. To further prove this, a mutant, STIM1-DI, was constructed by deleting residues 310-317 and was cotransfected with Orai1 into HEK-293 cells. As expected, STIM1-DI already formed puncta in quiescent cells and co-localized with Orai1 ( Figure 2E, upper panels) , just like that of STIM1-Y316A. Taken together, we propose that Tyr 316 plays a crucial role in keeping STIM1 in a closed conformation in the resting state and substitution of which with a non-aromatic amino acid would lead to spontaneous co-localization with Orai1 in the PM. A previous report showed that some mutants of STIM1 could co-localize with co-expressed Orai1 at the periphery of the cell in response to store depletion, but could not activate the CRAC channel [30] . Figure 3A) . Nevertheless, the peak [Ca 2 + ] i elevation upon re-addition of 2 mM Ca 2 + to the bath was not different between these kinds of transfected HEK-293 cells ( Figures 3A and 3C) , indicating that the ability of the mutant STIM1s to open the CRAC channel was not impaired. Figure 3(A) showed that STIM1-DI and STIM1-Y316A were still responsive to the stimulation of Ca 2 + store depletion and increased the [Ca 2 + ] i concentration from its initial levels despite being constitutively activated when co-expressed with Orai1, suggesting that mutant STIM1 was not in the maximally active state in the resting state. These results are in perfect accordance with the increased size of puncta by TG stimulation in both Figure S2 by confocal imaging. To verify that the constitutively active CRAC channels were not artefacts by overexpression of indicated proteins, HEK-293 cells were co-transfected with a very low amount of plasmids. As shown in Supplementary Figure S3 (at http://www.biochemj. org/bj/454/bj4540401add.htm), in cells co-expressing STIM1-DI/STIM1-Y316A and Orai1 at a lower level, the initial [Ca 2 + ] i was much higher than that in cells co-expressing the same level of WT STIM1 and Orai1, but a little bit lower than that in cells co-transfected with the amount of plasmids used above.
Figures 1 and 2 and Supplementary
Electrophysiological properties of the constitutively active STIM1-Y316A mutant
We used a Ca 2 + -imaging experiment to exhibit the change of global [Ca 2 + ] i . To obtain the subtle properties of the STIM1-Y316A mutant, the changes in the CRAC channel currents were monitored by a patch-clamp. No inward rectified currents were elicited in untransfected HEK-293 cells ( Figures 4A, 4B and 4C), suggesting that these cells do not contain the endogenous elements that form the CRAC channel. As shown in the timecourse measurements of CRAC channel currents in indicated cells (Figure 4C ), STIM1-Y316A produced a robust initial current immediately after break-in when co-transfected with Orai1.
Furthermore, STIM1-Y316A quickly responded to the decrease in [Ca 2 + ] i caused from the pipette solution containing 10 mM BAPTA, whereas WT STIM1 only exhibited a gradual increase in CRAC channel current 120 s after break-in. This result suggests that, although it is constitutively active, the mutant STIM1 was not maximized under physiological conditions. In contrast with WT STIM1, which required 420 s to achieve a maximum current, STIM1-Y316A reached a maximum current in 220 s ( Figure 4E ). These results further support the idea that STIM1-Y316A was already in a semi-active state. The peak current densities of STIM1-Y316A and WT STIM1 were not different ( Figure 4F) , indicating that the ability of the mutant STIM1 to open the CRAC channel was not impaired. On the basis of these results, we proposed that, when STIM1 was mutated to replace Tyr 316 with an alanine residue, the protein might transform from a closed conformation to an open one or eliminate the intermolecular repulsive forces among the STIM1s, both of which would lead to the easy formation of highly organized aggregations of STIM1. When the Ca 2 + stores were depleted, the ordered degree of STIM1 arrangement was strengthened, resulting in a greater activation of the CRAC channel.
In vitro evidence for Tyr 316 functioning in STIM1 aggregation
To prove further that Tyr 316 in the first inhibitory domain functions as a key amino acid to prevent aggregation of STIM1, the protein fragment containing both the auto-inhibitory domain and CAD (residues 246-455) and its Y316A mutant protein fragment were purified to analyse the property of aggregation. The gel-filtration chromatography experiment showed that both purified STIM1-(246-455) and STIM1-(246-455)-Y316A had a polymeric state and a dimeric state ( Figure 5A ). Yet apparently the introduction of the Y316A mutation into STIM1-(246-455) increased the proportion of polymeric component. To quantify the ratio of the two different fractions, we calculated the normalized peak area in STIM1-(246-455) and its Y316A mutant respectively ( Figure 5B ). As we could see in Figure 5 (C), the ratio of the polymeric component to the dimeric one of STIM1-(246-455)-Y316A was higher than that of STIM1-(246-455). The results suggest that the Y316A mutation could cause the aggregation of STIM1-(246-455), probably by releasing the first auto-inhibitory domain from the CAD.
DISCUSSION
In the present study, we identified an aromatic amino acid residue (Tyr 316 ) within the first inhibitory domain of STIM1 (residues 310-337) that played a crucial role in keeping STIM1 in a closed conformation in the resting state. Substitution of the tyrosine residue by a non-aromatic amino acid residue resulted in spontaneous STIM1 activation.
Our attention was drawn to the short segment of STIM1 (residues 310-317) primarily for the following reasons: first, CeSTM1 in HEK-293 cells formed a spontaneous cluster and bound to the PM in the resting state [22] , whereas hSTIM1 displayed a diffuse distribution in the ER without stimulation; secondly, the crystal structure of CeSTIM1 suggested that the first inhibitory domain (residues 310-337) of hSTIM1, which corresponds to a segment (residues 257-279) of CeSTIM1, may lock the CAD by intramolecular interactions using hydrogen and hydrophobic bonds; thirdly, the amino acid sequence alignment showed that hSTIM1 has an additional sequence (residues 310-317) in the first inhibitory domain, and CeSTIM1 has an incomplete first auto-inhibitory domain (Supplementary Figure Figure 4 Electrophysiological data showed that STIM1-Y316A could constitutively activate the CRAC channel in resting cells 
S1
). Therefore we guessed that the additional segment (residues 310-317) might lead to the different behaviour of hSTIM1 from that of CeSTIM1. By living-cell confocal imaging and in vitro experiments, we verified this short segment as a necessary element for keeping STIM1 in a rest state in resting cells and further identified a key amino acid, Tyr 316 , which was essential for the resting regulation. When the short segment (residues 310-317) was deleted or the Tyr 316 residue was mutated to an alanine, the STIM1 mutants could constitutively activate Orai1 in resting cells. In the present study, to avoid the toxicity of spontaneous Ca 2 + influx induced by co-expression of Orai1 and these STIM1 mutants, 1.75 mM EGTA and 10 μM LaCl 3 were simultaneously added to the medium. It was reported that La 3 + was an effective inhibitor of Ca 2 + pumps and an excess of La 3 + might effectively inhibit the activity of SERCA (sarcoplasmic/endoplasmic reticulum Ca 2 + -ATPase) or PMCA (PM Ca 2 + -ATPase) [31, 32] , which would lead to the accumulation of Ca 2 + in the cytosol. However, these studies also showed that La 3 + , when at a low concentration of below 10 μM, almost had no effect on the activity of Ca 2 + -ATPase, although it could inhibit >80 % of the activity of Ca 2 + -ATPase when it was at a high concentration above 200 μM. Moreover, Jan et al. [33] found that La 3 + had no inhibition in EGTA-containing Ca 2 + -free buffer, presumably because of the chelation of La 3 + by EGTA. Their results were consistent with a previous report, which showed that the affinity of EGTA for La 3 + is higher than that for Ca 2 +
[34]. Taken together, in the present study, we believe that La 3 + has little effect on the activity of PMCA/SERCA and contributes little to the constitutive activation of the STIM1 mutants, because the concentration of free La 3 + was far below 10 μM in the medium. As stated above, tyrosine residues have an aromatic ring sidechain and are hydrophobic amino acids. Chang et al. [35] suggested that hydrophobic interactions seemed to be the most influential forces in protein stability and folding, and side chains of aromatic amino acids play critical roles in the stability of 3D protein conformations. Statistical studies have shown that aromatic residues, especially tyrosine and tryptophan, can be found more frequently at the core of interactions as they establish energetically favourable interactions with the surrounding environment [36] . Moreira et al. [37] also showed that aromatic amino acid residues were the most commonly found hot-spots in protein-protein interactions.
On the basis of these reports and the results of the present study, we propose that STIM1 may be maintained in the closed conformation in resting states by two possible mechanisms, both of which may act through interaction with the Tyr 316 residue. The aromatic amino acid Tyr 316 might interact with the CAD using hydrogen and/or hydrophobic bonds. Conversely, Tyr 316 might act through intermolecular interactions among STIM1s using repulsive forces to maintain STIM1 in a dimer state. However, there is no apparent dividing line for the two possibilities. The two mechanisms might be related to each other. On the one hand, breaking the hydrogen and/or hydrophobic interaction between the inhibitory domain and the CAD by mutating Tyr 316 to an alanine might also induce the intermolecular interactions among STIM1s. On the other hand, the loss of the intermolecular repulsive forces among STIM1s by the Y316A mutation might The findings of the present study are meaningful for understanding the auto-inhibitory mechanism of STIM1 in the resting state. However, it is still unknown about how the Y316A mutation, but not the Y316F mutation, can release the autoinhibitory machinery and produce constitutively active STIM1. Further identification of key amino acids in the CAD or fulllength STIM1 that can interact with Tyr 316 would be very useful to understand the regulatory auto-inhibition. One way to determine the exact mechanism of STIM1 clustering and translocation to the PM is to solve the crystal structure of the full-length STIM1. Furthermore, knowledge of the STIM1-Orai1 complex crystal structure is especially helpful for illuminating the coupling machinery of CRAC channels. In each panel the same cell was displayed before (upper) and after (lower) treatment with 2 μM TG to deplete stores. For these confocal images, resting cells were imaged in 2 mM Ca 2 + Ringer's solution, and the same cells were store-depleted with 2 μM TG for 7 min. For these mutants with constitutive puncta, 1.75 mM EGTA and 10 μM La 3 + were added to the medium after transfection to avoid the toxicity of spontaneous Ca 2 + influx. 
AUTHOR CONTRIBUTION
